BIOMAT Database Logo BIOMAT Database Logo

Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. 1988

M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison.

In this study we have evaluated a possible role for brain serotoninergic neurons in the regulation of vasopressin secretion using pharmacological methods. In order to accomplish this, we have developed a specific and sensitive vasopressin radioimmunoassay along with a highly reproducible plasma extraction protocol. These tools were used to evaluate the plasma vasopressin response to several pharmacological challenges in conscious rats. Treatment with the serotonin (5-HT) releaser p-chloroamphetamine caused a significant increase in plasma vasopressin concentration. This effect was blocked by posterior hypothalamic deafferentation which separates serotonin cell bodies in the midbrain from their nerve terminals in the hypothalamus. Administration of graded doses of several 5-HT agonists had no effect. However, treatment with MK212, a serotonin agonist with 5-HT1 + 5-HT2 activity, induced a significant increase in plasma vasopressin concentration. The effect of MK212 on plasma vasopressin was completely abolished by the selective 5-HT2 receptor blocker LY53857. These studies confirm and extend studies by others that provide pharmacological evidence for serotoninergic regulation of vasopressin secretion via a selective 5-HT2 receptor mechanism. The specific neuroanatomical site(s) where serotonin exerts this effect are unknown, and the physiological consequences of these studies remain to be established.

UI MeSH Term Description Entries
D007026 Hypothalamic Area, Lateral Area in the hypothalamus bounded medially by the mammillothalamic tract and the anterior column of the FORNIX (BRAIN). The medial edge of the INTERNAL CAPSULE and the subthalamic region form its lateral boundary. It contains the lateral hypothalamic nucleus, tuberomammillary nucleus, lateral tuberal nuclei, and fibers of the MEDIAL FOREBRAIN BUNDLE. Lateral Hypothalamic Area,Lateral Hypothalamic Nucleus,Tuberomammillary Nucleus,Accessory Nucleus of the Ventral Horn,Area Hypothalamica Lateralis,Area Lateralis Hypothalami,Lateral Hypothalamus,Lateral Tuberal Nuclei,Lateral Tuberal Nucleus,Area Hypothalamica Laterali,Area Lateralis Hypothalamus,Area, Lateral Hypothalamic,Areas, Lateral Hypothalamic,Hypothalami, Area Lateralis,Hypothalamic Areas, Lateral,Hypothalamic Nucleus, Lateral,Hypothalamica Laterali, Area,Hypothalamica Lateralis, Area,Hypothalamus, Area Lateralis,Hypothalamus, Lateral,Lateral Hypothalamic Areas,Laterali, Area Hypothalamica,Lateralis Hypothalami, Area,Lateralis Hypothalamus, Area,Lateralis, Area Hypothalamica,Nuclei, Lateral Tuberal,Nucleus, Lateral Hypothalamic,Nucleus, Lateral Tuberal,Nucleus, Tuberomammillary,Tuberal Nuclei, Lateral,Tuberal Nucleus, Lateral
D008297 Male Males
D010133 p-Chloroamphetamine Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool. p-Chloramphetamine,para-Chloroamphetamine,LY-121860,Ly-123362,Parachloroamphetamine,LY 121860,LY121860,Ly 123362,Ly123362,p Chloramphetamine,p Chloroamphetamine,para Chloroamphetamine
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Opioid modulation of vasopressin secretion in conscious rats.
January 1988, Clinical and experimental hypertension. Part A, Theory and practice,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Splanchnic control of vasopressin secretion in conscious rats.
July 1990, The American journal of physiology,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Kappa-opioid modulation of vasopressin secretion in conscious rats.
June 1991, The Journal of endocrinology,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Inhibitory action of leumorphin on vasopressin secretion in conscious rats.
March 1988, Endocrinology,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Serotoninergic stimulation of gastrin secretion.
June 1978, Revista espanola de fisiologia,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Sympathetic activation following central vasopressin receptor stimulation in conscious rats.
December 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats.
February 1988, Hypertension (Dallas, Tex. : 1979),
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats.
December 1988, Neuroscience letters,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
August 1989, Endocrinology,
M S Brownfield, and J Greathouse, and S A Lorens, and J Armstrong, and J H Urban, and L D Van de Kar
Role of vasopressin in stimulation of ACTH secretion by angiotensin II in conscious dogs.
July 1986, The American journal of physiology,
Copied contents to your clipboard!